JK-05
JK-05 is an experimental antiviral drug developed by the Beijing Institute of Biotechnology and the Academy of Military Medical Sciences in China. It is designed to treat and prevent diseases caused by some filoviruses, including the Ebola virus and the Marburg virus.
Development[edit | edit source]
JK-05 was developed in response to the 2014–2016 Ebola virus epidemic in West Africa, which highlighted the need for effective treatments for filovirus diseases. The drug is named after Jiangsu Kanion Pharmaceutical, the company that manufactures it.
Mechanism of Action[edit | edit source]
JK-05 works by inhibiting the replication of the virus. It does this by blocking the action of a viral enzyme called RNA polymerase, which is necessary for the virus to reproduce.
Clinical Trials[edit | edit source]
In 2015, JK-05 was approved for emergency use in China, and it was also included in the national stockpile of emergency medicines. However, as of 2021, it has not yet been approved for general use, as it is still undergoing clinical trials.
See Also[edit | edit source]
JK-05 Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD